Clin2
NCT05124977Possibly a fitRecruiting

Antibiotic plan study for ventilator pneumonia in ICU

Ventilator Associated Pneumonia

Part of Infections, Lungs & breathing clinical trials.

This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
590 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must have your first confirmed ventilator-associated pneumonia (VAP) with positive lab testing
  • You must be on a breathing machine for more than 48 hours when the sample is taken
  • You must have signs of infection and worsening breathing/oxygen levels right before the first antibiotic dose
  • You must start an appropriate antibiotic plan around the time of diagnosis (even if initially “best guess”)
  • You (or your legal representative) must be able to give consent, including via an emergency process if needed

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05696093Recruiting· Phase 3
Cotrimoxazole for step-down treatment of ventilator pneumonia

This trial tests whether switching from an initial antibiotic to cotrimoxazole (a specific antibiotic combination) can work as well—or better—for ventilator-associated pneumonia in ICU patients. It aims to see if “de-escalating” antibiotics can control the infection while keeping vital signs stable.

Amiens
NCT07181824Recruiting
Diagnosing pneumonia in ventilated ICU patients

This trial looks at how well doctors followed current guidelines to diagnose ventilator-associated pneumonia (a lung infection from a breathing tube) in ICU patients between 2022 and 2024. It aims to improve future care.

Corbeil-Essonnes, France
NCT07052604Recruiting
Antibiotic treatment for a rare pneumonia in ICU patients

This study looks at how well antibiotics work for pneumonia caused by a specific bacterium (Stenotrophomonas maltophilia) in patients who are on breathing machines in the intensive care unit (ICU). It will help doctors choose the best treatment.

Saint-Denis, France
NCT05405491Recruiting
DNA test to guide antibiotic use for pneumonia in ICU patients

This study tests whether using a DNA test on lung fluid can help doctors choose better antibiotics for pneumonia in ICU patients with weakened immune systems. It may lead to more effective treatment and fewer side effects.

Lille
NCT07403474Not yet recruiting· Phase 4
Using a quick test and a treatment plan to choose the right antibiotics for pneumonia in the ICU

This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.

Nîmes
NCT06743529Recruiting
Immediate or watchful waiting for antibiotics in possible pneumonia

This trial compares starting antibiotics right away versus waiting for more test results in people on a breathing machine who may have pneumonia. The goal is to find out which approach works better without causing harm.

Angers, France

Hear when a new Ventilator Associated Pneumonia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.